Cannabis Use Disorder Overview
- Signs and Symptoms: Comorbidity with mood and anxiety disorders, challenges in discontinuing use, lower school performance in high school seniors, self-medication for psychiatric disorders.
- Dependency: Pharmacokinetic changes, tolerance to THC, development in about 9% of users, doubling of marijuana use in the US, contribution of changes in cannabinoid receptor function.
- Withdrawal: Symptoms like dysphoria, anxiety, and disturbed sleep, onset in the first week of abstinence, association with mood and anxiety disorders.
Causes and Risk Factors of Cannabis Dependency
- Causes: Prolonged and increasing use, escalation due to increased strength and delivery methods, genetic and environmental factors, influence of cannabinoid receptor function.
- Risk Factors: Young age of frequent use, personal maladjustment, early access to cannabis, genetic predisposition, positive early experiences predicting late dependence.
Treatment Approaches for Cannabis Use Disorder
- Treatment Options: Psychological interventions, pharmacological options, peer support, lack of effective medications.
- Psychological Interventions: CBT, MET, family interventions, focus on addressing cannabis use issues.
- Medication Approaches: Agonist substitution, antagonist, modulation, limited efficacy of certain medications.
Efficacy of Medications and Clinical Trials
- Medications: Mixed results with SSRIs, bupropion, atomoxetine, varying outcomes with different medications like baclofen, zolpidem, topiramate, and gabapentin.
- Clinical Trials: Mixed results with dronabinol and lofexidine, benefits of nabilone in reducing withdrawal symptoms, lack of strong evidence for some medications.
Epidemiology and Other Considerations
- Epidemiology: Cannabis as one of the most widely used drugs globally, 46% of US adults having used marijuana, cannabis being the most common illicit substance in US treatment facilities.
- Research: Impaired cognitive functioning with heavy use, need for further research on medications like THC preparations and oxytocin.
- Harm Reduction Strategies: Use of medications like nabilone, quetiapine, and oxytocin, over-the-counter antihistamines for short-term relief.
- Studies and Effects: Various studies on cannabinoid tolerance, clinical effects of medical cannabis, and the impact of cannabis use on human behavior.
Cannabis use disorder Data Sources
Reference | URL |
---|---|
Glossary | https:/glossary/cannabis-use-disorder |
Wikipedia | https://en.wikipedia.org/wiki/Cannabis_use_disorder |
Wikidata | https://www.wikidata.org/wiki/Q3743620 |
Knowledge Graph | |
DBPedia | http://dbpedia.org/resource/Cannabis_use_disorder |
Product Ontology | http://www.productontology.org/id/Cannabis_use_disorder |